SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 8.60 |
Enterprise Value ($M) | 5.73 |
Book Value ($M) | 5.53 |
Book Value / Share | 0.71 |
Price / Book | 1.56 |
NCAV ($M) | 3.94 |
NCAV / Share | 0.51 |
Price / NCAV | 2.18 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.97 |
Return on Assets (ROA) | -0.46 |
Return on Equity (ROE) | -2.68 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.94 |
Current Ratio | 1.53 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 16.93 |
Assets | 18.52 |
Liabilities | 12.99 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Rosalind Advisors, Inc. | |||
13G/A | Hirschman Orin | |||
13D/A | Deutsche Balaton Aktiengesellschaft | |||
13G/A | Armistice Capital, Llc | 4.99 | 73.19 | |
13G/A | Lytton Laurence W | 9.99 | 9.04 | |
13G/A | Saad Nabil | 0.00 | -100.00 | |
13G/A | Bigger Capital, LLC | -98.01 | ||
13G | Hewlett Fund LP | 9.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
56,806 | 148,199 | 38.33 | |
11,107 | 56,324 | 19.72 | |
9,038 | 43,714 | 20.68 | |
2,483 | 22,134 | 11.22 | |
(click for more detail) |
Similar Companies | |
---|---|
BCLI – Brainstorm Cell Therapeutics Inc. | BCTX – BriaCell Therapeutics Corp. |
BFRG – Bullfrog AI Holdings, Inc. | BGM – BGM Group Ltd. |
BIVI – BioVie Inc. |
Financial data and stock pages provided by
Fintel.io